A desperate plea for life-saving cancer treatment has President Trump stepping in to help the embattled ‘Dilbert’ creator, Scott Adams.
Quick Take
- President Trump has promised to assist Scott Adams in obtaining cancer treatment.
- Adams claims his healthcare provider delayed his treatment scheduling.
- Kaiser Permanente affirms ongoing collaboration with Adams’ oncology team.
- Pluvicto, the drug in question, reportedly reduces cancer progression risk by 28%.
Trump’s Direct Response to Scott Adams’ Plea
On November 2, 2025, President Donald Trump responded to a public appeal from Scott Adams, creator of the ‘Dilbert’ comic strip, who is battling metastatic prostate cancer.
Adams reached out on social media, expressing an urgent need for treatment with the drug Pluvicto, which his healthcare provider, Kaiser Permanente of Northern California, delayed in scheduling. Trump promptly assured Adams, stating, “On it,” highlighting his commitment to assist a supporter in need.
Trump responds to ‘Dilbert’ creator Scott Adams’ plea for help to obtain cancer treatment: ‘On it’ https://t.co/SiLDjei42J pic.twitter.com/dqGgXTW4ok
— New York Post (@nypost) November 3, 2025
Challenges in Adams’ Treatment Process
Scott Adams voiced his frustration over Kaiser Permanente’s handling of his treatment approval. While the healthcare provider had agreed to use Pluvicto, Adams noted their failure to timely schedule the necessary intravenous infusion.
Despite this setback, Kaiser Permanente released a statement affirming that Adams’ oncology team is actively working on his case and that advancements in his cancer care are underway.
Since its approval, Kaiser Permanente has successfully treated over 150 patients in Northern California with Pluvicto, a drug that merges radioactive particles with tumor-targeting molecules.
The drug’s manufacturer, Swiss company Novartis, disclosed that Pluvicto decreases the risk of cancer progression or death in prostate cancer patients by 28%.
Support from the Trump Administration
The White House did not provide a formal response regarding Adams’ situation, yet Secretary of Health and Human Services Robert F. Kennedy echoed Trump’s promise to assist. This intervention underscores the administration’s willingness to support American citizens, particularly those who have been loyal to President Trump.
Scott Adams’ case also serves as a reminder of the broader issues within the healthcare system, where bureaucratic delays can have dire consequences for patients in critical need. The involvement of high-profile figures highlights the necessity for efficient and responsive healthcare services, especially for life-threatening conditions.
